Controlled ovarian stimulation and triggers in in vitro fertilization: Protocol personalization key to optimize outcomes

Jacqueline Y. Maher, Mindy Sue Christianson

Research output: Contribution to journalReview articlepeer-review

Abstract

The past four decades have delivered many advancements to improve in vitro fertilization (IVF) outcomes. These include a delicate balance of controlled ovarian hyperstimulation (COH) without causing ovarian hyperstimulation syndrome (OHSS), a safe oocyte retrieval, fertilization and embryo culture, endometrial growth and receptivity to promote implantation, and luteal support to maintain the pregnancy. Contemporary IVF practice includes both the classic COH protocols as well as protocols for poor responders and those for specific patient populations. An assortment of agents have been developed and utilized in various combinations to improve COH outcomes and promote oocyte maturation while decreasing the risk of OHSS. Various protocols have evolved over time. Ideal practices involve selecting the optimal protocol for a personalized, patient-specific stimulation and trigger.

Original languageEnglish (US)
Pages (from-to)37-49
Number of pages13
JournalMinerva Endocrinologica
Volume43
Issue number1
DOIs
StatePublished - Mar 1 2018

Keywords

  • Fertilization in vitro
  • Gonadotropins
  • Letrozole
  • Leuprolide
  • Menotropins
  • Ovulation induction

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'Controlled ovarian stimulation and triggers in in vitro fertilization: Protocol personalization key to optimize outcomes'. Together they form a unique fingerprint.

Cite this